Expression Genetics
in Drug Therapy
Participating Sites:
| XGEN Ohio State University | Columbus, OH | |
| Nationwide Children's Hospital Columbus Team | Columbus, OH | |
| University of Florida | Gainesville, FL | |
| National Heart, Lung, and Blood Institute | Bethesda, MD | |
| University of California | San Diego, CA | |
| University of Bari | Bari, Italy |
Funded by NIGMS U01 GM092655
XGEN is a member of the NIH Pharmacogenomics Research Network.
The OSU Program in Pharmacogenomics is the primary home for the network group.
XGEN is a member of the NIH Pharmacogenomics Research Network.
The OSU Program in Pharmacogenomics is the primary home for the network group.
The Program in Pharmacogenomics - housed primarily in the Department of Pharmacology - is an OSU campus-wide program directed by Professor Wolfgang Sadée. Members of the Program come from the Department of Pharmacology and other basic sciences or clinical departments in the College of Medicine, The College of Pharmacy, The College of Public Health, The Comprehensive Cancer Center, and The Heart & Lung Institute.
The Program in Pharmacogenomics is also the home of XGEN (Expression Genetics in Drug Therapy), group member of the NIH Pharmacogenomics Network (W. Sadée, Director), dedicated to discovery of clinical biomarkers as guides in individualized therapy. Collaboration Site.
